![IJERPH | Free Full-Text | Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study IJERPH | Free Full-Text | Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study](https://pub.mdpi-res.com/ijerph/ijerph-18-05173/article_deploy/html/images/ijerph-18-05173-ag.png?1621574814)
IJERPH | Free Full-Text | Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study
![Remote Sensing | Free Full-Text | Deriving Non-Cloud Contaminated Sentinel-2 Images with RGB and Near-Infrared Bands from Sentinel-1 Images Based on a Conditional Generative Adversarial Network Remote Sensing | Free Full-Text | Deriving Non-Cloud Contaminated Sentinel-2 Images with RGB and Near-Infrared Bands from Sentinel-1 Images Based on a Conditional Generative Adversarial Network](https://pub.mdpi-res.com/remotesensing/remotesensing-13-01512/article_deploy/html/images/remotesensing-13-01512-ag.png?1619320427)
Remote Sensing | Free Full-Text | Deriving Non-Cloud Contaminated Sentinel-2 Images with RGB and Near-Infrared Bands from Sentinel-1 Images Based on a Conditional Generative Adversarial Network
![Elementary labour market indicators in Slovakia in the selected years... | Download Scientific Diagram Elementary labour market indicators in Slovakia in the selected years... | Download Scientific Diagram](https://www.researchgate.net/publication/335788956/figure/tbl1/AS:802523216621569@1568347853625/Elementary-labour-market-indicators-in-Slovakia-in-the-selected-years-by-place-of-birth.png)
Elementary labour market indicators in Slovakia in the selected years... | Download Scientific Diagram
![Palobiofarma completed the dose escalation part of the Phase I study with PBF-999 in cancer patients - Palobiofarma Home Palobiofarma completed the dose escalation part of the Phase I study with PBF-999 in cancer patients - Palobiofarma Home](https://www.palobiofarma.com/wp-content/uploads/2018/10/october-2018-1170x650.jpg)